Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-1-28
pubmed:abstractText
Approximately 36 million women in the United States are in the postmenopausal phase of life. The vast majority of these women experienced spontaneous cessation of menses between the ages of 47 and 55 years when the production of estrogen decreased because of an inadequate number of functioning follicles within their ovaries. Fewer women entered menopause after surgical removal of both ovaries. This procedure usually is performed prophylactically to prevent ovarian cancer in conjunction with a hysterectomy, which is required to treat abnormal bleeding, endometriosis or pelvic inflammatory disease. The physiological changes associated with spontaneous or surgical menopause cause some women to experience uncomfortable symptoms such as hot flashes, night sweats and vaginal dryness. In addition, estrogen deprivation arising from menopause in association with age-related factors disproportionately increases the risk of developing cardiovascular disease (that is, myocardial infarct, stroke), osteoporosis, Alzheimer's disease and oral disease. Hormone replacement therapy, or HRT (estrogen or estrogen and progestin), often is prescribed on a short-term basis to alleviate the uncomfortable symptoms associated with estrogen deficiency and on a long-term basis to prevent some of the chronic illnesses common to postmenopausal women.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0002-8177
pubmed:author
pubmed:issnType
Print
pubmed:volume
133
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-81
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11811747-Alzheimer Disease, pubmed-meshheading:11811747-Estrogens, pubmed-meshheading:11811747-Female, pubmed-meshheading:11811747-Hormone Replacement Therapy, pubmed-meshheading:11811747-Hot Flashes, pubmed-meshheading:11811747-Humans, pubmed-meshheading:11811747-Menopause, pubmed-meshheading:11811747-Middle Aged, pubmed-meshheading:11811747-Mouth Diseases, pubmed-meshheading:11811747-Myocardial Infarction, pubmed-meshheading:11811747-Osteoporosis, Postmenopausal, pubmed-meshheading:11811747-Ovariectomy, pubmed-meshheading:11811747-Ovary, pubmed-meshheading:11811747-Periodontal Diseases, pubmed-meshheading:11811747-Postmenopause, pubmed-meshheading:11811747-Saliva, pubmed-meshheading:11811747-Stroke, pubmed-meshheading:11811747-Sweating, pubmed-meshheading:11811747-Taste Disorders, pubmed-meshheading:11811747-Tooth Diseases, pubmed-meshheading:11811747-Vagina
pubmed:year
2002
pubmed:articleTitle
The physiology, medical management and oral implications of menopause.
pubmed:affiliation
Veterans Affairs Greater Los Angeles Healthcare System, Calif 90073, USA. arthur.friedlander@med.va.gov
pubmed:publicationType
Journal Article, Review